The Patent Finder

Indazole Inhibitors of the WNT Signal Pathway and Therapeutic Uses Thereof (2010)

Biosplice Therapeutics, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 6 of these applications claim priority to application 61/232,603, filed Aug 10, 2009. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 8,252,812Indazole Inhibitors of the WNT Signal Pathway and Therapeutic Uses Thereof
In force
 · High confidence
UsedRemaining
Biosplice Therapeutics, Inc.In forceHigh confidence
US 8,703,794Indazole Inhibitors of the WNT Signal Pathway and Therapeutic Uses Thereof
In force
 · High confidence
Biosplice Therapeutics, Inc.In forceHigh confidence
US 9,090,613Indazole Inhibitors of the WNT Signal Pathway and Therapeutic Uses Thereof
In force
 · High confidence
Biosplice Therapeutics, Inc.In forceHigh confidence
US 9,381,192Indazole Inhibitors of the WNT Signal Pathway and Therapeutic Uses Thereof
In force
 · High confidence
Biosplice Therapeutics, Inc.In forceHigh confidence
US 9,763,927Indazole Inhibitors of the WNT Signal Pathway and Therapeutic Uses Thereof
In force
 · High confidence
Biosplice Therapeutics, Inc.In forceHigh confidence
US 8,822,478Indazole Inhibitors of the WNT Signal Pathway and Therapeutic Uses Thereof
In force
 · High confidence
Biosplice Therapeutics, Inc.In forceHigh confidence
US 8,604,052Indazole Inhibitors of the WNT Signal Pathway and Therapeutic Uses Thereof
Lapsed Dec 10, 2025 on the fee record
High confidence
Biosplice Therapeutics, Inc.Lapsed Dec 10, 2025 on the fee recordHigh confidence
US 10,016,406Indazole Inhibitors of the WNT Signal Pathway and Therapeutic Uses Thereof
Lapsed Jul 10, 2026 on the fee record
Medium confidence
Biosplice Therapeutics, Inc.Lapsed Jul 10, 2026 on the fee recordMedium confidence
8 of 8 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
6 of these are in force and held by Biosplice Therapeutics, Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited